Heart Disease Trial, Recruiting NCT07518862 Sponsor: University Health Network, Toronto Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT07518862
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are older than 18 years of age
  • People who are currently receiving a type of oxygen therapy delivered through a nasal tube that uses high-flow air (called High-Flow Nasal Cannula Therapy)

Who may not be able to join:

  • People whose oxygen concentration setting is 90% or higher
  • People who have an irregular heart rhythm called atrial fibrillation, or whose heart is controlled by a pacemaker
  • People who have recently had heart surgery
  • People who have a condition or injury that prevents the use of certain monitoring equipment placed on the chest, such as an active implanted medical device, burns, or wounds on the chest area (confirm with trial site)
  • People who do not speak English

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 4163404800 ext 7613

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 May 2026
Est. completion
1 November 2026

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Change in heart rate variability during flow titration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov